HZN-825 QD ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04781543 (ClinicalTrials.gov)	April 1, 2021	1/3/2021	A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 i ...	A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Effic ...	Diffuse Cutaneous Systemic Sclerosis;Sclerosis, Systemic	Drug: HZN-825 BID;Drug: Placebo;Drug: HZN-825 QD	Horizon Therapeutics Ireland DAC	NULL	Recruiting	18 Years	75 Years	All	300	Phase 2	United States;Argentina;Austria;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Mexico;N ...

First Previous1Next Last